transforming care and outcomes with immunotherapy in stage i-iii resectable nsclc
Published 2 months ago • 438 plays • Length 48:02Download video MP4
Download video MP3
Similar videos
-
1:05:29
can the addition of immunotherapy to multimodal management of stage i-iii nsclc improve outcomes?
-
59:37
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
49:11
how to integrate perioperative immunotherapy into multimodal treatment plans in resectable nsclc
-
59:24
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
48:44
neoadjuvant, adjuvant, or both: individualized perioperative immunotherapy in resectable nsclc
-
1:27:28
the continuing success story of immunotherapy in nsclc
-
1:11:21
maximizing the potential of immunotherapy in unresectable stage iii nsclc
-
1:44:45
gaining an advantage over nsclc: how to achieve the greatest benefit with immunotherapy
-
39:06
unleashing the potential of perioperative immunotherapy in resectable nsclc
-
1:29:06
leveraging neoadjuvant and adjuvant immunotherapy to improve outcomes in early-stage cancers
-
7:44
immunotherapy in stage iii nsclc
-
1:03:14
changing the game for es-sclc with immunotherapy and multidisciplinary collaboration
-
1:06:01
drs. altorki & spicer discuss immunotherapy advances in stage i-iii nsclc: https://bit.ly/3hvzzoz
-
36:55
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
1:22:09
illuminating the path with immunotherapy for metastatic, locally advanced, and early stage nsclc
-
1:08:56
toward better outcomes in sclc: immunotherapy has changed the game, but where do we go next?
-
1:06:23
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
1:02:02
improving outcomes in molecularly altered nsclc through precision testing and treatment
-
3:44
immunotherapy as combination and neoadjuvant therapies in nsclc